Leveraging its lawyers’ experience as government officials in regulatory and policy agencies, Hogan Lovells International LLP's Greater China life sciences practice is consistently sought out to for complex regulatory issues. The team advises at all stages of life sciences products, from initial clinical trials to off-patent strategy, business development and defence-side litigation The team also advises on new technology-driven areas, such as digital health, AI, gene therapy and regenerative medicine. On the mainland, Lu Zhou advises life sciences and healthcare clients on cross-border transactions; and Calvin Ding represents companies (and their board committees) in relation to corruption, conflicts of interest, trade compliance and cybersecurity incidents. Jessie Xie's practice covers regulatory work and commercial contracts in the pharmaceutical, medical devices, healthcare, food, and cosmetics sectors.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Distinctions
La satisfaction du client
Clients clés
- Sinopharm Commonwealth Company
- Merck Sharp & Dohme
- Aspen
Points forts
- Advised Sinopharm Commonwealth Company on making a pre-conditional proposal to privatise China Traditional Chinese Medicine Holdings Co.
- Acted for Merck Sharp & Dohme in cross-border litigation concerning rights to the MERCK trade mark and trade name.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Meilleurs collaborateurs
Jeunes avocats collaborateurs ou counsels qui se distinguent régulièrement par leur présence dans des dossiers importants du marché, et qui sont identifiés par le marché comme de jeunes talents à suivre.
Responsable de la pratique
Lu Zhou; Calvin Ding
Autres avocats clés
Jessie Xie; Adrian Emch; Roy Zou; Andrew McGinty; Sammy Li; Tony Mou